Atlas Trials

Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT02058433 · UNKNOWN

Trial details

NCT number
NCT02058433
Sponsor
Caicun Zhou
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2014-01-01
Primary completion
2015-12-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.